로딩 중…
StockDiggingStockDigging

휴비츠

065510· KOSDAQ
₩6,990-2.92%
2026-06-19

Price Chart

휴비츠-10.84%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap76.04B KRW
Revenue117.84B KRW
Net Income-5.01B KRW
Total Assets229.97B KRW
Net Assets114.37B KRW
Employees271
Value
P/B0.66x
P/S0.65x
FCF Yield7.25%
Profitability
ROE-4.38%
ROA-2.18%
Op. Margin-2.32%
Revenue Growth-0.69%
Earnings Growth3824.72%
Financial Health
Debt Ratio201.06%
Total Debt75.17B KRW
FCF5.51B KRW
Cash5.90B KRW
Current Ratio1.09x
Dividend
Div. Yield3.47%
Div. Growth25.00%
Performance
1Y Return-10.84%
1M Return-2.51%
From 52W High-30.72%
1Y MDD-32.35%
Trading
Volume72,017 shares
Foreign Own.3.93%
Per Share
EPS-320 KRW
BPS10,194 KRW

Company Info

CEO 김현수
Employees 271
Founded 1999
HQ 경기도 안양시, KR

Huvitz, established in 1999 and listed on the KOSDAQ market in 2003, plans to expand its implant business by acquiring shares in Osview in 2025. As a specialized ophthalmic medical device company, Huvitz produces South Korea's first optical coherence tomography diagnostic devices and auto refractometers, expanding its business across all optometric fields. The company invests over 10% of its annual revenue in research and development, with R&D personnel comprising 33% of its workforce, growing into a top-tier company in the ophthalmic diagnostic field. Huvitz is headquartered in Anyang-si, Gyeonggi-do.